Literature DB >> 19324082

C3G silencing enhances STI-571-induced apoptosis in CML cells through p38 MAPK activation, but it antagonizes STI-571 inhibitory effect on survival.

Vera Maia1, María Sanz, Javier Gutierrez-Berzal, Alberto de Luis, Alvaro Gutierrez-Uzquiza, Almudena Porras, Carmen Guerrero.   

Abstract

In this work we report evidences of a functional relationship between C3G and p38 MAPK in the apoptotic effect of STI-571 on the chronic myeloid leukemia (CML) cell line K562. This has been demonstrated by knocking down C3G and p38alpha using the interfering RNA approach, as well as through targeting p38 by its inhibitor SB203580. The results indicate that p38 is a mediator of the STI-571-induced apoptosis, while C3G plays a negative role on STI-571-mediated p38 activation through a Rap1-dependent mechanism. According to this, gene expression analysis in C3G silenced cells revealed an upregulation of a large number of genes involved in apoptosis. Some of these genes are also down-regulated (at the protein level) upon p38alpha knock-down, which further suggests a functional association between these two proteins. On the other hand, C3G knock-down reverts the STI-571-inhibitory effect on ERKs and Akt pathways in a Rap1-independent fashion. Moreover, C3G overexpression also increased both, basal and STI-571-induced apoptosis, in agreement with previous reports. Therefore, our results strongly suggest a dual regulatory role for C3G in CML cells, modulating both apoptosis and survival via Rap-dependent and independent mechanisms.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19324082     DOI: 10.1016/j.cellsig.2009.03.015

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  10 in total

1.  C3G contributes to platelet activation and aggregation by regulating major signaling pathways.

Authors:  Cristina Fernández-Infante; Luis Hernández-Cano; Sara Gutiérrez-Herrero; Sara Ortiz-Rivero; Carlos Guijas; Víctor Martín-Granado; José Ramón González-Porras; Jesús Balsinde; Almudena Porras; Carmen Guerrero
Journal:  Signal Transduct Target Ther       Date:  2020-04-01

2.  C3G downregulation induces the acquisition of a mesenchymal phenotype that enhances aggressiveness of glioblastoma cells.

Authors:  Alvaro Gutierrez-Uzquiza; Carmen Guerrero; Almudena Porras; Sara Manzano; Paloma Bragado; Celia Sequera; Óscar Herranz; María Rodrigo-Faus; Patricia Jauregui; Stephanie Morgner; Ignacio Rubio
Journal:  Cell Death Dis       Date:  2021-04-06       Impact factor: 8.469

Review 3.  Talin‑1 interaction network in cellular mechanotransduction (Review).

Authors:  Ye Zhao; Nikita Lykov; Chimeng Tzeng
Journal:  Int J Mol Med       Date:  2022-03-10       Impact factor: 4.101

4.  C3G down-regulation enhances pro-migratory and stemness properties of oval cells by promoting an epithelial-mesenchymal-like process.

Authors:  Nerea Palao; Celia Sequera; Ángel M Cuesta; Cristina Baquero; Paloma Bragado; Alvaro Gutierrez-Uzquiza; Aránzazu Sánchez; Carmen Guerrero; Almudena Porras
Journal:  Int J Biol Sci       Date:  2022-09-25       Impact factor: 10.750

5.  C3G forms complexes with Bcr-Abl and p38α MAPK at the focal adhesions in chronic myeloid leukemia cells: implication in the regulation of leukemic cell adhesion.

Authors:  Vera Maia; Sara Ortiz-Rivero; María Sanz; Javier Gutierrez-Berzal; Indira Alvarez-Fernández; Sara Gutierrez-Herrero; Jose María de Pereda; Almudena Porras; Carmen Guerrero
Journal:  Cell Commun Signal       Date:  2013-01-23       Impact factor: 5.712

6.  MiR-362-5p promotes the malignancy of chronic myelocytic leukaemia via down-regulation of GADD45α.

Authors:  Peng Yang; Fang Ni; Rui-Qing Deng; Guo Qiang; Hua Zhao; Ming-Zhen Yang; Xin-Yi Wang; You-Zhi Xu; Li Chen; Dan-Lei Chen; Zhi-Jun Chen; Li-Xin Kan; Si-Ying Wang
Journal:  Mol Cancer       Date:  2015-11-06       Impact factor: 27.401

7.  C3G knock-down enhances migration and invasion by increasing Rap1-mediated p38α activation, while it impairs tumor growth through p38α-independent mechanisms.

Authors:  Neibla Priego; María Arechederra; Celia Sequera; Paloma Bragado; Ana Vázquez-Carballo; Álvaro Gutiérrez-Uzquiza; Víctor Martín-Granado; Juan José Ventura; Marcelo G Kazanietz; Carmen Guerrero; Almudena Porras
Journal:  Oncotarget       Date:  2016-07-19

8.  C3G promotes a selective release of angiogenic factors from activated mouse platelets to regulate angiogenesis and tumor metastasis.

Authors:  Víctor Martín-Granado; Sara Ortiz-Rivero; Rita Carmona; Sara Gutiérrez-Herrero; Mario Barrera; Laura San-Segundo; Celia Sequera; Pedro Perdiguero; Francisco Lozano; Francisco Martín-Herrero; José Ramón González-Porras; Ramón Muñoz-Chápuli; Almudena Porras; Carmen Guerrero
Journal:  Oncotarget       Date:  2017-11-06

Review 9.  How Rap and its GEFs control liver physiology and cancer development. C3G alterations in human hepatocarcinoma.

Authors:  Celia Sequera; Sara Manzano; Carmen Guerrero; Almudena Porras
Journal:  Hepat Oncol       Date:  2018-04-16

10.  C3G contributes to platelet activation and aggregation by regulating major signaling pathways.

Authors:  Cristina Fernández-Infante; Luis Hernández-Cano; Sara Gutiérrez-Herrero; Sara Ortiz-Rivero; Carlos Guijas; Víctor Martín-Granado; José Ramón González-Porras; Jesús Balsinde; Almudena Porras; Carmen Guerrero
Journal:  Signal Transduct Target Ther       Date:  2020-04-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.